Trials / Conditions / Hyperlipoproteinemia Type III
Hyperlipoproteinemia Type III
3 registered clinical trials studyying Hyperlipoproteinemia Type III.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | Effects of Evolocumab Versus Placebo Added to Standard Lipid-lowering Therapy on Fasting and Post Fat Load Lip NCT03811223 | UMC Utrecht | Phase 4 |
| Terminated | Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Disorder. NCT00145431 | Pfizer | Phase 3 |
| Completed | Type III Dysbetalipoproteinemia NCT00214604 | AstraZeneca | Phase 3 |